Case Control Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2014; 20(20): 6302-6308
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6302
Figure 2
Figure 2 Distribution of the human leukocyte antigen risk groups in cases and controls according to tag-single nucleotide polymorphism prediction. Low risk for those negative for DQ2/DQ8; intermediate risk for those homozygous for HLA-DQ2.2 or DQ8, heterozygous for DQ2.5 or DQ2.2; high risk for those homozygous for DQ2.5 and DQ2.5/DQ2.2. HLA: Human leukocyte antigen.